← Leaderboards
Satish N Nadig
Medical University Of South Carolina
$5,662,552
Attributed
$6,342,481
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,342,481 · 5
By mechanism
U01$2,999,652 · 1
R01$1,947,404 · 1
K08$587,169 · 1
R21$448,256 · 1
R56$360,000 · 1
Top collaborators
- Paul R Carlier1 shared
- Zheng J Zhang1 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- John J Lemasters$27,282,033
- Loretta L. Jophlin$690,478
- Robert J Boackle$789,579
- Jason L Blum$75,106
Others in their field
Top investigators on “Clinical Translation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$362,430,297
- Lee Marshall Nadler · Dana-Farber Cancer Inst$361,563,148
- Steven E Reis · University Of Pittsburgh At Pittsburgh$284,283,938
- David Heimbrook · Leidos Biomedical Research, Inc.$263,662,106
- Gregory H Reaman · National Childhood Cancer Foundation$262,423,799
- Garret A Fitzgerald · University Of Pennsylvania$213,440,250
Research focus
Clinical TranslationExperimental StudyAllograftingInflammatorySolidEndothelial CellsClinically RelevantTransplantationOrgan TransplantationReperfusion InjuryPharmaceutical PreparationsOrganAntigen PresentationResponseAcuteMediatingLongevityCytokineIn VivoPhenotypeGraft SurvivalGraft RejectionIn VitroReperfusion Therapy
Grant awards (15)
A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)$999,859
U01 · FY2025 · GM · contact PI
Mitigating IRI-induced CMV reactivation by targeting endothelial stress responses$360,000
R56 · FY2025 · AI
A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)$999,855
U01 · FY2024 · GM · contact PI
Ex vivo maintenance of endothelial cell barrier integrity via gap junction modification to prevent early ischemic injury in solid organ transplantation$197,143
R21 · FY2024 · AI · contact PI
A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)$999,938
U01 · FY2023 · GM · contact PI
Modulating endothelial cell immunometabolism and mitochondrial morphologyimplications for organ transplantation$397,906
R01 · FY2023 · AI · contact PI
Ex vivo maintenance of endothelial cell barrier integrity via gap junction modification to prevent early ischemic injury in solid organ transplantation$251,113
R21 · FY2023 · AI · contact PI
Modulating endothelial cell immunometabolism and mitochondrial morphologyimplications for organ transplantation$399,019
R01 · FY2022 · AI · contact PI
Modulating endothelial cell immunometabolism and mitochondrial morphologyimplications for organ transplantation$265,059
R01 · FY2022 · AI · contact PI
Modulating endothelial cell immunometabolism and mitochondrial morphology- implications for organ transplantation$137,920
R01 · FY2021 · AI · contact PI
Modulating endothelial cell immunometabolism and mitochondrial morphology- implications for organ transplantation$373,750
R01 · FY2020 · AI · contact PI
Modulating endothelial cell immunometabolism and mitochondrial morphology- implications for organ transplantation$373,750
R01 · FY2019 · AI · contact PI
Nanoparticle Therapy for Targeted Drug Delivery in Organ Transplantation$195,723
K08 · FY2018 · EB · contact PI
Nanoparticle Therapy for Targeted Drug Delivery in Organ Transplantation$195,723
K08 · FY2017 · EB · contact PI
Nanoparticle Therapy for Targeted Drug Delivery in Organ Transplantation$195,723
K08 · FY2016 · EB · contact PI